Click here to access Business Weekly's ten year archive of East of England 'Life Sciences' articles
|
|
Antibodies specialist raises 17.5 million pounds |
|
Written by Tony Quested
|
|
Wednesday, 12 March 2008 |
|
Dutch-owned Cambridge antibodies specialist PanGenetics has raised 23 Million Euro (£17.5m) in Series C financing to fund clinical advancement of its therapeutic antibody programmes. |
|
|
Pronostics has high hopes for German diagnostics distribution deal |
|
Written by Ben Fountain
|
|
Wednesday, 12 March 2008 |
Cambridge diagnostics company, Pronostics has signed a distribution agreement with German company, Medipan for technology that allows doctors to diagnose autoimmune diseases.
|
|
|
Written by News Desk
|
|
Wednesday, 12 March 2008 |
|
Healthcare giant, Johnson & Johnson Pharmaceutical Research & Development (J&J PRD), has renewed its collaboration agreement with BioWisdom’s OmniViz for the license rights to the information visualisation and data mining OmniViz software. |
|
|
Austrian antibody start-up heads to Cambridge |
|
Written by Ben Fountain
|
|
Wednesday, 12 March 2008 |
Austrian antibody engineering start-up, f-Star plans to open a Cambridge research facility next month.
|
|
|
Bio ‘virgins’ handed passport to global glory |
|
Written by News Desk
|
|
Wednesday, 12 March 2008 |
|
Biotech SMEs in the East of England cluster are being handed a unique chance to expand globally through an exciting new initiative from East of England International.
|
|
|
Alizyme raises £10m as losses widen |
|
Written by News Desk
|
|
Wednesday, 12 March 2008 |
|
Cambridge biopharma development firm Alizyme announced a £10m institutional share placing on the same day it revealed a £13.7m increase in its pre-tax losses for the last financial year. |
|
|
MMI announces vote on termination of founders' contracts |
|
Written by Ben Fountain
|
|
Wednesday, 12 March 2008 |
|
First blood has been drawn in what may yet still prove to be a protracted battle for control of virtual drug development company, Medical Marketing International (MMI).
|
|
|
Genzyme plans on growing Cambridge base |
|
Written by Ben Fountain
|
|
Tuesday, 11 March 2008 |
 Following hot on the heels of the announcement that it is to invest "tens of millions of pounds" in its Haverhill manufacturing facility, US biotech giant, Genzyme has revealed that it intends to significantly expand its Cambridge research base.
|
|
|
Online antibodies business is booming |
|
Written by Sam Fountain
|
|
Monday, 10 March 2008 |
|
Internet antibody retailer, Abcam has reported a 19 per cent increase in pre-tax profits for the first half of the year, with sales up by a third.
|
|
|
Newmarket based bloodstock investment boutique gallops to £2.7m of £4m target |
|
Written by Ben Fountain
|
|
Thursday, 06 March 2008 |
|
A Newmarket based bloodstock investment boutique is under starter’s orders with its second fund having raised £2.7m of its £4m target. |
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
|
| Results 69 - 85 of 140 |
Life Sciences 
